|
|
|
| Webinar: Inside the Development of an AAV8 Production Platform Designed for Scale | Adeno-associated virus (AAV) vectors are pivotal in gene therapy, yet their production faces significant challenges, including scalability, low recovery rates, and the need for effective separation of empty and full capsids. This webinar presents a comprehensive AAV8 production platform developed together with CDMO Matica Biotechnology, and addresses industry pain points through innovative upstream and downstream processes. Click here to learn more. |
|
|
|
|
Cell & Gene Live explored the cutting-edge manufacturing technologies impacting cell therapy production. Our expert panel delved into innovative approaches such as automation solutions for increased efficiency, strategies for optimizing cell therapy delivery, and more. |
|
|
|
| Making MSCs GMP: A Compliant Workflow | Webinar | Terumo BCT | Generate GMP-compliant mesenchymal stem cells (MSCs) at scale with a closed, automated workflow. Learn how to optimize MSC harvest yields and ensure trilineage differentiation. |
|
|
|
|
|
|
| Continuous Monitoring And Control Of Glucose And Lactate | Application Note | 908 Devices | This experiment demonstrates that continuous real-time monitoring of glucose and lactate and dynamic glucose feed control to a low-level set-point leads to improved process and product parameters. |
|
|
|
|
| A Full-Service Solution Partner Disrupting the Outsourcing Paradigm | inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them. |
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
